Is bluebird bio, Inc. (NASDAQ:BLUE) a Long Term Growth Play? Shares have moved 17.83% YTD

Shaers of bluebird bio, Inc. (NASDAQ:BLUE) have been recommended as a long term growth pick.  With the firm’s stock price currently trading around $116.89, the firm has proven a solid track record of growth over the recent years.  Investors might consider the stock as a long term growth candidate as the firm has yielded 17.50% earnings per share growth over the past 5 years and 153.30% revenue growth over that same time frame. 

High yielding stocks can be very tempting for investors. Trying to maximize the return on every dollar invested is a goal of many individuals. What investors have to remember is that the stocks that promise the highest return potential may also be some of the riskiest to own. Because past performance can’t guarantee future results, investors may need to do some extra research when adding high risk stocks to the portfolio. Most investors are always on the lookout to spot that next big stock winner before everyone else. Making sure that they are not adding too much extra risk when doing this may be the key to keeping the portfolio balanced. 

Long-term growth (LTG) is an investing strategy where a stock will (hopefully) grow in value for a relatively long period of time.  Long-term growth should be considered to be a relative term, due to different styles and goals of investors, but the endgame is the same. 

Recent Performance

Let’s take a look at how the stock has been performing recently.  Over the past twelve months, bluebird bio, Inc. (NASDAQ:BLUE)’s stock was 17.83%.  Over the last week of the month, it was 17.03%, -14.22% over the last quarter, and  -34.46% for the past six months. 

Over the past 50 days, bluebird bio, Inc.’s stock is -16.35% off of the high and 33.60% removed from the low.  Their 52-Week High and Low are as follows: -50.51% (High), 33.60%, (Low). 

Analyst Recommendation

Despite the past success, investors want to know where the stock is headed from here.  Analysts covering the shares have a consensus short-term price target of $180.24 on the equity.   Analysts have a consensus recommendation of 1.90 based on a 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.  

Stock market investing can sometimes become highly emotional. Being able to leave emotions out of the major investing decisions might be tricky, but it may end up being a portfolio savior down the road. Nobody wants to see a thoroughly researched stock pick underperform. Holding onto the hope that a certain stock has to bounce back may lead to later problems. Of course, it can be very hard for humans to admit when a mistake was made. Finding the ability to detach from a position can be tough. Humans make mistakes, but being able to learn from those mistakes moving forward can help with achieving long term success in the market.